(NP (NP (JJ Comparative) (NN analysis)) (PP (IN of) (NP (NP (NP (NP (NN NFAT)) (PRN (-LRB- -LRB-) (NP (NP (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (-RRB- -RRB-))) (JJ complex)) (PP (IN in) (NP (JJ human) (NP-COOD (NP (NN T)) (CC and) (NP (NN B))) (NNS lymphocytes))))) (. .))
(S (NP-SBJ-2 (NP (NP (JJ Nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NFAT)) (-RRB- -RRB-))) (VP-COOD (VP (VBZ is) (NP-PRD (NP (DT a) (JJ transcriptional) (NN activator)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (-NONE- *T*-1)) (VP (VBZ binds) (PP (TO to) (NP (NP (NNS sequences)) (PP (IN in) (NP (DT the) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (NN promoter)))))))))) (CC and) (VP (VBZ is) (VP (VBN thought) (S (NP-SBJ (-NONE- *-2)) (VP (TO to) (VP (VB be) (ADJP-PRD (RB largely) (JJ responsible) (PP (IN for) (NP (NP (DT the) (ADJP (NN T) (JJ cell-specific)) (NN inducibility)) (PP (IN of) (NP (NN IL-2) (NN expression)))))))))))) (. .))
(S (NP-SBJ (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-3 (JJ specific) (NN NFAT) (NN binding) (NN activity)) (VP (MD could) (ADVP (RB also)) (VP (VB be) (VP (VBN induced) (NP (-NONE- *-3)) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))))))) (. .))
(S (NP-SBJ (DT The) (NN B) (NN cell) (NN NFAT) (NN complex)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD was) (RB not) (ADJP-PRD (JJ functional)) (, ,) (SBAR (IN since) (S (NP-SBJ-4 (PRP it)) (VP (VBD failed) (S (NP-SBJ (-NONE- *-4)) (VP (TO to) (VP (VB activate) (NP (NP (NN transcription)) (PP (IN from) (NP (DT an) (JJ NFAT-driven) (NP (NP (NN chloramphenicol) (NN acetyltransferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-))) (NN construct))))))))))) (. .))
(S (NP-SBJ (NP (NN Competition)) (PP-COOD (PP (IN with) (NP (DT an) (NN AP-1) (NN motif))) (CC or) (PP (IN with) (NP (ADJP-COOD (ADJP (JJ anti-Jun)) (CC and) (ADJP (JJ anti-Fos))) (NNS antibodies))))) (VP (VBD abolished) (NP (NP (NN binding)) (PP (TO to) (NP (DT the) (NN NFAT) (NN motif))) (PP (IN in) (NP (NP-COOD (CC both) (NP (NN T)) (CC and) (NP (NN B))) (NNS cells)))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ-COOD (NP (NN Jun)) (CC and) (NP (NN Fos))) (VP (VBP are) (ADJP-PRD (JJ critical) (PP (IN for) (NP (NP (NN NFAT) (NN complex) (NN formation)) (PP (IN in) (NP (DT both) (NN cell) (NNS types)))))))))))) (. .))
(S (NP-SBJ-5 (VBN Purified) (JJ recombinant) (NP-COOD (NP (NN Jun)) (CC and) (NP (NN Fos))) (NNS proteins)) (VP (VBD failed) (S (NP-SBJ (-NONE- *-5)) (VP (TO to) (VP (VB bind) (ADVP (RB directly)) (PP (TO to) (NP (DT the) (NN NFAT) (NN motif))))))) (. .))
(S (ADVP (RB However)) (, ,) (SBAR-TMP (WHADVP-9 (WRB when)) (S (NP-SBJ-8 (-NONE- *-7)) (VP (VBN combined) (NP (-NONE- *-8)) (PP (IN with) (NP (JJ unstimulated) (NP-COOD (NP (NN B)) (CC or) (NP (NN T))) (NN cell) (NNS extracts))) (ADVP (-NONE- *T*-9))))) (, ,) (NP-SBJ-6 (ADJP-COOD (ADJP (JJ full-length)) (, ,) (CC but) (ADJP (RB not) (VBN truncated)) (, ,)) (NN (Fos Jun)) (NNS heterodimers)) (VP (VBD were) (ADJP-PRD (JJ able) (S (NP-SBJ-7 (-NONE- *-6)) (VP (TO to) (VP (VB form) (NP (DT an) (NN NFAT) (NN complex)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG indicating) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (ADJP (RB constitutively) (VBN expressed)) (JJ nuclear) (NN factor) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-))) (PP (IN in) (NP (NP-COOD (NP (NN B)) (CC and) (NP (NN T))) (NNS cells))) (ADJP (JJ necessary) (PP (IN for) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (DT the) (NN NFAT) (NN complex))))) (PP (IN in) (NP (DT both) (NN cell) (NNS types)))))))))))) (. .))
(S (NP-SBJ-10 (NP (DT An) (NN NFAT) (NN oligonucleotide)) (VP (VBG carrying) (NP (NNS mutations)) (PP (IN in) (NP (NP (DT the) (JJ 5') (JJ purine-rich) (NN part)) (PP (IN of) (NP (DT the) (NN NFAT) (NN sequence))))))) (VP (VBD failed) (S (NP-SBJ (-NONE- *-10)) (VP (VP-COOD (VP (TO to) (VP (VB form) (NP (DT a) (NN complex)))) (CC and) (VP (TO to) (VP (VB compete) (PP (IN with) (NP (DT the) (JJ wild) (NN type) (NN motif))) (PP (IN for) (NP (NN NFAT) (NN complex) (NN formation)))))) (PP (IN in) (NP (NP-COOD (CC both) (NP (NN T)) (CC and) (NP (NN B))) (NNS cells)))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB therefore)) (VP (VBP propose) (NP (NP (DT a) (NN model)) (SBAR (WHADVP-11 (WRB whereby)) (S (S-COOD (S (NP-SBJ-12 (NP (DT a) (NN core) (NN NFAT) (NN complex)) (VP (VBG consisting) (PP (IN of) (NP-COOD (NP (NN Jun)) (, ,) (NP (NN Fos)) (, ,) (CC and) (NP (DT a) (JJ constitutive) (JJ nuclear) (NN factor)))))) (VP (VBZ is) (VP (VBN formed) (NP (-NONE- *-12)) (PP (IN in) (NP (NP-COOD (DT both) (NP (NN T)) (CC and) (NP (NN B))) (NNS cells)))))) (, ,) (CC but) (S (NP-SBJ-13 (NP-COOD (NP (DT an) (JJ additional) (NN factor)) (CC (or and)) (NP (NP (JJ post-translational) (NN modification)) (PP (IN of) (NP (DT a) (NN factor))))) (, ,) (ADJP (VBG missing) (PP (IN in) (NP (NN B) (NNS cells)))) (, ,)) (VP (MD might) (VP (VB be) (VP (VBN required) (NP (-NONE- *-13)) (PP (IN for) (NP (NP (NN transactivation)) (PP (IN by) (NP (NN NFAT)))))))))) (ADVP (-NONE- *T*-11)))))) (. .))
